- PR Newswire•10 days agoLifshitz & Miller LLP Announces Investigation of Centrue Financial Corporation, Motorola Solutions, Inc., Natus Medical Incorporated, Northern Dynasty Minerals Ltd., Ocera Therapeutics, Inc., Psychemedics Corporation, RH and Stemline Therapeutics, Inc.
NEW YORK, Feb. 17, 2017 /PRNewswire/ -- Centrue Financial Corporation (CFCB) Lifshitz & Miller announces an investigation into possible breaches of fiduciary duties by the board of directors of CFCB ...
- Business Wire•26 days agoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Ocera Therapeutics, Inc.
Levi & Korsinsky announces it has commenced an investigation of Ocera Therapeutics, Inc. concerning possible violations of federal securities laws.
- GlobeNewswire•29 days ago
Primary and Secondary Endpoints Showed Trend and Dose-Related Clinical Benefit Although Not Statistically Significant. Ammonia Scavenger OCR-002 Demonstrated Statistically Significant Reduction in Ammonia ...
6TY1.SG : Summary for Ocera Therapeutics Inc. Registe - Yahoo Finance
Ocera Therapeutics, Inc. (6TY1.SG)
Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
As of 10:32AM CET. Market open.
|Bid||0.57 x 150000|
|Ask||0.59 x 150000|
|Day's Range||0.57 - 0.57|
|52 Week Range||0.35 - 0.57|
|PE Ratio (TTM)||-0.42|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|